Form D · Other Health Care
Genben Lifesciences Corp
San Diego, CA · CIK 0001560760
Offering snapshot reported May 16, 2018 · SEC filing
- Reported sold
- $5.18M Offering amount: $5.18M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 4, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 16, 2018 | Initial | $5,178,335 | No comparison | 5 | SEC filing |
| Oct 24, 2012 | Initial | $1,100,005 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-312586
Includes amounts paid both in cash and pursuant to automatic conversion of indebtedness.
Source: Form D, filed May 16, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Xiao Chang Dai | Director |
| Kenneth Fong | Director |
| Yishan Li | Director |
| Li Shen | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
6370 Lusk Blvd Suite F205
San Diego, CA, 92121
San Diego, CA, 92121